Chemometec AS 

€40.24
29
-€0.28-0.69% Thursday 06:05

Statistics

Day High
38.08
Day Low
38.08
52W High
105.6
52W Low
36.82
Volume
-
Avg. Volume
-
Mkt Cap
700.26M
P/E Ratio
73.64
Dividend Yield
2.33%
Dividend
0.94

Upcoming

Dividends

2.33%Dividend Yield
Oct 25
€0.94
Oct 24
€0.54
Oct 23
€0.8
Oct 20
€0.25
Jan 20
€2.29
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
5.23%
1Y Growth
N/A

Earnings

4FebExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
3.18
4.33
5.48
6.63
Expected EPS
6.62953825128
Actual EPS
5.3592075684

Financials

37.61%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
132.86MRevenue
49.98MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CHY.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a wide range of analytical instruments and laboratory equipment, competing in the cell analysis market similar to ChemoMetec.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation, through its subsidiaries, provides various biotech and life sciences products, including cell imaging and analysis systems that compete with ChemoMetec's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. produces and supplies systems for the life science research and clinical diagnostics markets, including cell counting and imaging products.
Agilon Health
AGL
Mkt Cap330.09M
Agilent Technologies provides instruments, services, and consumables for laboratories worldwide, including cell analysis technologies that rival ChemoMetec's.
Illumina
ILMN
Mkt Cap18.99B
Illumina, Inc. offers sequencing and array-based solutions for genetic analysis, which competes with ChemoMetec's cell analysis technologies in the genomics and research sectors.
Repligen
RGEN
Mkt Cap8.39B
Repligen Corporation supplies bioprocessing technologies and systems that are used in the production of biological drugs, competing indirectly by offering complementary technologies for cell analysis.
Bio-Techne
TECH
Mkt Cap9.74B
Bio-Techne Corporation develops, manufactures, and sells life sciences reagents, instruments, and services for research, including cell and gene analysis products that compete with ChemoMetec.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen N.V. provides sample to insight solutions that transform biological materials into valuable molecular insights, including cell analysis technologies that compete with ChemoMetec's offerings.

About

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5, a versatile cell analyzer. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerod, Denmark.
Show more...
CEO
Mr. Martin Helbo Behrens
Employees
170
Country
DK
ISIN
DK0060055861
WKN
000A0MS80

Listings

0 Comments

Share your thoughts

FAQ

What is Chemometec AS stock price today?
The current price of CHY.F is €40.24 EUR — it has decreased by -0.69% in the past 24 hours. Watch Chemometec AS stock price performance more closely on the chart.
What is Chemometec AS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Chemometec AS stocks are traded under the ticker CHY.F.
Is Chemometec AS stock price growing?
CHY.F stock has risen by +2.34% compared to the previous week, the month change is a -28.21% fall, over the last year Chemometec AS has showed a -37.85% decrease.
What is Chemometec AS market cap?
Today Chemometec AS has the market capitalization of 700.26M
When is the next Chemometec AS earnings date?
Chemometec AS is going to release the next earnings report on September 10, 2026.
What were Chemometec AS earnings last quarter?
CHY.F earnings for the last quarter are 0.72 EUR per share, whereas the estimation was 0.89 EUR resulting in a -19.16% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Chemometec AS revenue for the last year?
Chemometec AS revenue for the last year amounts to 132.86M EUR.
What is Chemometec AS net income for the last year?
CHY.F net income for the last year is 49.98M EUR.
Does Chemometec AS pay dividends?
Yes, CHY.F dividends are paid annual. The last dividend per share was 0.94 EUR. As of today, Dividend Yield (FWD)% is 2.33%.
How many employees does Chemometec AS have?
As of April 05, 2026, the company has 170 employees.
In which sector is Chemometec AS located?
Chemometec AS operates in the Health Care sector.
When did Chemometec AS complete a stock split?
Chemometec AS has not had any recent stock splits.
Where is Chemometec AS headquartered?
Chemometec AS is headquartered in Allerod, DK.